Security
ARGOS THERAPEUTICS INC Common Stock · ARGSQ
ARGSQOTCCommon stockHistorical · closed Sep 25, 2019CIK 1105533Updated Nov 16, 2026
Name history
MERIX BIOSCIENCE INC · through Oct 12, 2004
ARGSQ price & chart
Historical security
This listing closed Sep 25, 2019. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2017 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 20,777,764Source | 97,204,391Source | 31,131,202Source | 64,366,878Source |
| Property, Plant and Equipment, NetUSD | 3,582,323Source | 40,951,577Source | 22,306,384Source | 5,513,555Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 15,188,838Source | 52,973,376Source | 6,163,144Source | 37,223,590Source |
| Assets, CurrentUSD | 17,184,421Source | 55,501,794Source | 8,813,798Source | 57,517,303Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,252,134Source | 940,106Source | 740,173Source | 838,420Source |
| Other Assets, NoncurrentUSD | 11,020Source | 11,020Source | 11,020Source | 11,020Source |
| LIABILITIES AND EQUITY | ||||
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | — |
| Common Stock, Value, IssuedUSD | 5,907Source | 41,263Source | 21,642Source | 19,657Source |
| Additional Paid in CapitalUSD | 363,450,204Source | 338,249,457Source | 250,873,875Source | 235,627,174Source |
| Retained Earnings (Accumulated Deficit)USD | -372,564,327Source | -331,986,817Source | -278,958,707Source | -204,170,186Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -125,864Source | -134,208Source | -138,245Source | -124,841Source |
| Stockholders' Equity Attributable to ParentUSD | -9,234,080Source | 6,169,695Source | -28,201,435Source | 31,351,804Source |
| Liabilities and EquityUSD | 20,777,764Source | 97,204,391Source | 31,131,202Source | 64,366,878Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 9,557,166Source | 30,609,838Source | 8,162,813Source | 3,296,754Source |
| Accounts Payable, CurrentUSD | 970,650Source | 5,377,377Source | 2,907,683Source | 1,860,491Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 1,263,867Source | 9,980,891Source | 3,676,846Source | 1,405,378Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | 53,000,000Source | 7,200,000Source | — |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesUSD | — | 11,475,480Source | 1,578,284Source | 30,885Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 12,133,543Source | 18,673,298Source | 30,821,761Source | 19,796,545Source |
| Short-term InvestmentsUSD | — | — | 1,003,160Source | 19,016,347Source |
cash flow · annual statements
| Line item | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -53,305,938Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 967,891Source | 952,341Source | 680,444Source | 566,117Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 8,867,616Source | 5,103,494Source | 4,014,938Source | 3,013,283Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | -2,222,657Source | 1,193,590Source | -136,981Source | 543,419Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -35,424,886Source | — | — | — |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 316,273Source | — | — | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | 3,674,358Source | 15,329,980Source | 9,686,643Source | 1,097,798Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -2,684,153Source | — | — | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 766,776Source | — | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 8,867,616Source | 5,394,492Source | 4,014,938Source | 3,013,283Source |
| Amortization of Debt Issuance CostsUSD | — | 34,004Source | 216,424Source | 69,308Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | 53,000,000Source | 7,200,000Source | — |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | 2,767,540Source | — | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 2,767,540Source | -11,865Source | -2,799Source | 1,710Source |
| Gain (Loss) on Extinguishment of DebtUSD | 2,356,478Source | — | — | — |
| General and Administrative ExpenseUSD | 12,183,235Source | 14,203,301Source | 11,011,011Source | 8,599,359Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Investment Income, InterestUSD | 64,485Source | 57,326Source | 25,382Source | 66,580Source |
| Net Income (Loss) Attributable to ParentUSD | -40,577,510Source | -53,028,110Source | -74,788,521Source | -53,305,938Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | -53,028,110Source | -74,788,521Source | -54,169,164Source |
| Nonoperating Income (Expense)USD | 21,881,047Source | -721,927Source | -2,241,016Source | -1,181,682Source |
| Operating ExpensesUSD | 64,357,955Source | 53,251,651Source | 73,065,834Source | 54,098,275Source |
| Other Nonoperating Income (Expense)USD | 9,860Source | — | — | — |
| Proceeds from Stock Options ExercisedUSD | — | 133,571Source | 201,067Source | 12,810Source |
income statement · annual statements
| Line item | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|
| Total RevenueUSD | 1,899,398Source | 945,468Source | 518,329Source | 1,974,019Source |
| Operating Income (Loss)USD | -62,458,557Source | -52,306,183Source | -72,547,505Source | -52,124,256Source |
| Other Nonoperating Income (Expense)USD | 9,860Source | — | — | — |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -40,577,510Source | -53,028,110Source | -74,788,521Source | -53,305,938Source |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 12,183,235Source | 14,203,301Source | 11,011,011Source | 8,599,359Source |
| Interest ExpenseUSD | 1,308,201Source | 1,774,740Source | 2,263,599Source | 1,123,579Source |
| Investment Income, InterestUSD | 64,485Source | 57,326Source | 25,382Source | 66,580Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | -53,028,110Source | -74,788,521Source | -54,169,164Source |
| Nonoperating Income (Expense)USD | 21,881,047Source | -721,927Source | -2,241,016Source | -1,181,682Source |
| Operating ExpensesUSD | 64,357,955Source | 53,251,651Source | 73,065,834Source | 54,098,275Source |
| Other IncomeUSD | — | 0Source | 0Source | 140,556Source |
| Research and Development ExpenseUSD | 21,656,096Source | 38,307,236Source | 62,054,823Source | 45,498,916Source |